ASGCT Education Program Returns, Covers Parkinson's Disease

The American Society of Gene & Cell Therapy (ASGCT) is proud to launch a second round of disease-specific resources in its Patient Education program. The first of the seven new resources focuses on developing gene therapies for Parkinson’s disease.

Watch ASGCT's Gene Therapy for
Parkinson's Disease Video

ASGCT will release brand new resources weekly through the end of November on the new Patient Education portal. Designed by ASGCT committee volunteers in coordination with patient advocacy groups, the patient-centered portal aims to educate and inform patients, families, and the public on the status and promise of gene and cell therapies.

The Patient Education resources on Parkinson’s disease are now available on ASGCT.org. Parkinson’s is a degenerative neurological disease that causes the death of brain cells, called neurons, over time. Gene therapy for Parkinson’s may offer hope for managing symptoms or improving the effects of existing medications.

The full schedule for ASGCT’s new Patient Education resources to be released during the remainder of 2019, excepting one-week breaks for the ASGCT Policy Summit and Thanksgiving, is as follows:

• Huntington’s disease—October 15
• Muscular dystrophy—October 24
• MPS (Mucopolysaccharidosis)—October 29
• Hemophilia— November 12
• Pompe—November 19
• CAR T Basics—December 3

Related Articles